ROCKET PHARMACEUTICALS, INC. (RCKT) Form 8-K Material Events
ROCKET PHARMACEUTICALS, INC. (RCKT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RCKT
CIK: 1281895
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerMarc Fogarty
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-06 | 2026-09-30 | 8-K | 0001140361-26-038818 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001140361-26-036688 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001959173-26-006989 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001140361-26-036563 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001959173-26-006938 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001959173-26-006908 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001959173-26-006907 | View SEC Doc Filr Page |
| 25-NSE | 2026-09-02 | — | 25-NSE Filing | 0001354457-26-000844 | View SEC Doc Filr Page |
| 8-K | 2026-08-27 | 2026-08-21 | 8-K | 0001140361-26-034689 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 Filing | 0001140361-26-033915 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 Filing | 0001140361-26-033913 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001959173-26-006169 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001959173-26-006168 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001959173-26-006166 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | FORM 4 | 0001140361-26-033417 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | FORM 4 | 0001140361-26-033413 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001140361-26-032818 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001140361-26-032816 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001959173-26-005995 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001959173-26-005994 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001959173-26-005892 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001959173-26-005891 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001140361-26-032028 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-342348 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0001140361-26-031473 | View SEC Doc Filr Page |